前收市價 | 95.76 |
開市 | 95.88 |
買盤 | 92.92 x 1700 |
賣出價 | 93.48 x 1700 |
今日波幅 | 93.16 - 95.98 |
52 週波幅 | 93.16 - 134.35 |
成交量 | |
平均成交量 | 28 |
市值 | 5.908B |
Beta 值 (5 年,每月) | 0.58 |
市盈率 (最近 12 個月) | 20.89 |
每股盈利 (最近 12 個月) | 4.46 |
業績公佈日 | 2024年8月06日 - 2024年8月14日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 208.50 |
We recently compiled a list of the 8 Best Pot Stocks to Buy. In this article, we are going to take a look at where Jazz Pharmaceuticals plc (NASDAQ:JAZZ) stands against the other pot stocks. The history of the cannabis industry is riddled with changes and conflicting legislation. The international media has played an important […]
While innovations such as artificial intelligence have become all the rage, there’s another type of technology – biotechnology – that deserves careful consideration for your portfolio. Indeed, if you haven’t considered the sector, it’s really time to focus on biotech stocks. First, let’s get the obvious matter out of the way: biotech stocks benefit broadly from a permanently relevant narrative. That doesn’t mean individual companies are guaranteed to rise. It’s just that the concept of addressin
With the federal government taking steps to reschedule cannabis to Schedule III, effectively creating a form of medical cannabis legalization, the future of cannabis stocks is under intense scrutiny. While cannabis stocks initially surged on the news, they quickly settled back to their previous levels. This response is due to the potential disruption a medical cannabis mandate might bring, creating uncertainty that has made investors cautious about committing to any particular cannabis stock rig